TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression

The CBM Complex Underwrites NF- B Activation to Promote HER2-Associated Tumor Malignancy

(2015) D. Pan et al.   MOLECULAR CANCER RESEARCH

MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression

(2015) D Pan et al.   ONCOGENE

Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada

(2012) Annika F.M. Haywood et al.   EUROPEAN HEART JOURNAL

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

(2011) Bo Li et al.   BMC BIOINFORMATICS

CARMA3 is Crucial for EGFR-Induced Activation of NF- B and Tumor Progression

(2011) T. Jiang et al.   CANCER RESEARCH

NF-κB signaling pathways regulated by CARMA family of scaffold proteins

(2010) Marzenna Blonska et al.   CELL RESEARCH

Visualization of molecular interactions using bimolecular fluorescence complementation analysis: Characteristics of protein fragment complementation

(2009) Tom K. Kerppola   CHEMICAL SOCIETY REVIEWS

Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Is a Fully Penetrant, Lethal Arrhythmic Disorder Caused by a Missense Mutation in the TMEM43 Gene

(2008) Nancy D. Merner et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Shared Principles in NF-κB Signaling

(2008) Matthew S. Hayden et al.   CELL

LUMA interacts with emerin and influences its distribution at the inner nuclear membrane

(2008) Luiza Bengtsson et al.   JOURNAL OF CELL SCIENCE

 -Arrestin 2 is required for lysophosphatidic acid-induced NF- B activation

(2008) J. Sun et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA